Information about Amgen Inc. is available at .

Information about Amgen Inc. is available at .

Chugai Pharmaceutical aspires for development of innovative drugs by integrating cutting-edge technologies into its unique drug discovery infrastructure. Funneling resources into prescription drugs, Chugai is pursuing research and development of antibody drug-centered biopharmaceuticals in five franchises; cancer, renal, cardiovascular, bone/joint, and transplantation/immunology/infectious diseases while actively working on the traditional chemical cynthesis drug discovery. Based on high ethical and moral standards for a life science enterprise, Chugai, with its Patient-First philosophy, is committed to contributing to society by developing innovative drugs enabling higher patients' QOL and better lives.

Additional information about Chugai is available at .

Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs.

Additional information about Lilly is available at .

Information about Merck is available at .

Information about Teijin is available at